» Articles » PMID: 36129711

Effectiveness of Acupuncture for Anxiety Among Patients With Parkinson Disease: A Randomized Clinical Trial

Overview
Journal JAMA Netw Open
Specialty General Medicine
Date 2022 Sep 21
PMID 36129711
Authors
Affiliations
Soon will be listed here.
Abstract

Importance: One of the ordinary manifestations of Parkinson disease (PD) is anxiety, which remains untreated. Anxiety is closely associated with the accelerated progression of PD. Efficacy of acupuncture for anxiety has been reported. However, to date, there are no data on acupuncture's effectiveness on anxiety for patients with PD.

Objective: To investigate the effect of acupuncture vs sham acupuncture for treating anxiety in patients with PD.

Design, Setting, And Participants: This is randomized, double-blinded, clinical trial enrolled patients between June 20, 2021, and February 26, 2022. Final follow-up was April 15, 2022. Patients with Parkinson disease and anxiety were allocated randomly (1:1) to receive acupuncture or sham acupuncture for 8 weeks. Acupuncture operators, outcome measures evaluators, and statistical analysts were blinded to the grouping of patients. Patients were blinded to their own grouping during the study. This study took place in the Parkinson clinic of a hospital in China.

Interventions: Real acupuncture or sham acupuncture for 8 weeks.

Main Outcomes And Measures: Primary outcome was Hamilton Anxiety Scale (HAM-A) score. Secondary outcomes were scores on the Unified Parkinson Disease Rating Scale (UPDRS), 39-item Parkinson Disease Questionnaire (PDQ-39), and serum levels of the adrenocorticotropic hormone (ACTH) and cortisol (CORT).

Results: Seventy eligible patients were enrolled, including 34 women (48.5%) and 36 men (51.4%). Sixty-four patients (91%) completed the intervention and the 8-week follow-up, including 30 women (46.9%) and 34 men (53.1%) with a mean (SD) age of 61.84 (8.47) years. At the end of treatment, the variation of HAM-A score was 0.22 (95% CI, -0.63 to 1.07; P = .62) between the real acupuncture and sham acupuncture groups. At the end of follow-up, the real acupuncture group had a significant 7.03-point greater (95% CI, 6.18 to 7.88; P < .001) reduction in HAM-A score compared with the sham acupuncture group. Four mild adverse reactions occurred during the study.

Conclusions And Relevance: This study found acupuncture to be an effective treatment for anxiety in patients with PD. These findings suggest that acupuncture may enhance the wellbeing of patients who have Parkinson disease and anxiety.

Trial Registration: Chinese Clinical Trial Registry: ChiCTR2100047253.

Citing Articles

Clinical efficacy and potential mechanisms of acupuncture for Parkinson's disease: the role of GABAergic signaling.

Lu W, Zhang T, Li M, Zhang J, Liu N, Yang L Front Neurosci. 2025; 19:1525486.

PMID: 40046435 PMC: 11880233. DOI: 10.3389/fnins.2025.1525486.


Levodopa-synergistic CBT intervention improves Parkinson's disease with anxiety disorder by regulating the BDNF/PI3K/AKT pathway.

Ji N, Lu S, Xu B, Guan X, Xian Z, Geng D Neurol Sci. 2025; .

PMID: 39937424 DOI: 10.1007/s10072-025-07988-0.


Comment on "Effect of Acupuncture Intervention on Chronic Musculoskeletal Pain in Hemodialysis-Dependent Kidney Failure Patients: Study Protocol for a Randomized Controlled Clinical Trial" [Letter].

He L, Lv S J Pain Res. 2025; 18():203-204.

PMID: 39830678 PMC: 11740545. DOI: 10.2147/JPR.S513596.


Corticostriatal glutamate-mediated dynamic therapeutic efficacy of electroacupuncture in a parkinsonian rat model.

Jiang X, Sun M, Yan Y, Wang Y, Fan X, Wei J Clin Transl Med. 2024; 14(12):e70117.

PMID: 39627032 PMC: 11614550. DOI: 10.1002/ctm2.70117.


Efficacy of acupuncture in ameliorating anxiety in Parkinson's disease: a systematic review and meta-analysis with trial sequential analysis.

Wu Z, Liu C, Chan V, Wu X, Huang F, Guo Z Front Aging Neurosci. 2024; 16:1462851.

PMID: 39588511 PMC: 11586373. DOI: 10.3389/fnagi.2024.1462851.


References
1.
Weintraub D, Aarsland D, Chaudhuri K, Dobkin R, Leentjens A, Rodriguez-Violante M . The neuropsychiatry of Parkinson's disease: advances and challenges. Lancet Neurol. 2021; 21(1):89-102. PMC: 8800169. DOI: 10.1016/S1474-4422(21)00330-6. View

2.
Seo S, Bang S, Kang S, Cho S, Choi K, Ryu Y . Acupuncture Alleviates Anxiety and 22-kHz Ultrasonic Vocalizations in Rats Subjected to Repeated Alcohol Administration by Modulating the Brain-Derived Neurotrophic Factor/Corticotropin-Releasing Hormone Signaling Pathway. Int J Mol Sci. 2021; 22(8). PMC: 8070810. DOI: 10.3390/ijms22084037. View

3.
Errington-Evans N . Acupuncture for anxiety. CNS Neurosci Ther. 2011; 18(4):277-84. PMC: 6493505. DOI: 10.1111/j.1755-5949.2011.00254.x. View

4.
Dissanayaka N, White E, OSullivan J, Marsh R, Silburn P, Copland D . Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease. Mov Disord Clin Pract. 2018; 2(2):155-162. PMC: 6183244. DOI: 10.1002/mdc3.12157. View

5.
Verber D, Novak D, Borovic M, Dugonik J, Flisar D . EQUIDopa: A responsive web application for the levodopa equivalent dose calculator. Comput Methods Programs Biomed. 2020; 196:105633. DOI: 10.1016/j.cmpb.2020.105633. View